Semin Respir Crit Care Med 2002; 23(6): 505-512
DOI: 10.1055/s-2002-36515
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Neuromuscular Sarcoidosis

Alvin Teirstein
  • Mt. Sinai Medical Center, New York, New York
Further Information

Publication History

Publication Date:
07 January 2003 (online)

ABSTRACT

Neuromuscular sarcoidosis is recognized with increasing frequency. Although reported to occur in only 5% of patients with sarcoidosis, major centers are reporting up to 20% neuromuscular involvement. While the majority of patients with neurologic involvement present with 7th nerve palsy, the reported frequency of sarcoidosis of the brain, meninges, spinal cord, and muscles is rising.

The diagnosis of neuromuscular sarcoidosis is usually accepted when a patient with previous biopsy-proven sarcoidosis presents with a compatible neurologic syndrome. In addition to cranial nerve abnormalities, these syndromes include leptomeningitis, seizures, mass lesions of brain and spinal cord, pituitary dysfunction, and neuropathies. Occasionally, the typical intrathoracic, ocular, cutaneous and lymph node presentations of sarcoidosis are not present or are unrecognized and the diagnosis is established by biopsy of neuromuscular tissue. Biopsy exhibiting granulomas is not specific and requires absence of evidence of known granulomagenic agents plus presence of multiorgan disease. An isolated granuloma in neural tissue without other organ involvement is not diagnostic of sarcoidosis.

Treatment of neuromuscular sarcoidosis is usually prolonged. Facial palsy often improves spontaneously. Prednisone is still the drug of choice. Most authorities agree that 30 to 40 mg qd is sufficient with concomitant azathioprine or cyclophosphamide.

REFERENCES

  • 1 Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases.  Ann Intern Med . 1977;  87 336-345
  • 2 Stern B J, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations.  Arch Neurol . 1985;  42 909-917
  • 3 Oksanen V. Neurosarcoidosis: clinical presentations and course in 50 patients.  Acta Neurol Scand . 1986;  73 283-290
  • 4 Chapelon C, Ziza J M, Piette J C. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases.  Medicine . 1990;  69 261-276
  • 5 Newman L S, Rose C S, Maier L A. Sarcoidosis.  N Engl J Med . 1997;  336 1224-1234
  • 6 Ricker W, Clark M. Sarcoidosis: a clinicopathological review of three hundred cases, including twenty-two autopsies.  Am J Clin Pathol . 1949;  19 725-749
  • 7 Manz H J. Pathobiology of neurosarcoidosis and clinicopathologic correlation.  Can J Neurol Sci . 1983;  10 50-55
  • 8 Urich H. Neurosarcoidosis or granulomatous angiitis: a problem of definition.  Mt Sinai J Med . 1977;  44 718-725
  • 9 Jaster J H, Dohan Jr C F, Bertorini T E. Solitary spinal cord sarcoidosis without other manifestations of systemic sarcoidosis.  Clin Imag . 1997;  21 17-22
  • 10 Sommer N, Weller M, Petersen D, Wietholter H, Dichgans J. Neurosarcoidosis without systemic sarcoidosis.  Eur Arch Psychiatry Clin Neurosci . 1991;  240 334-338
  • 11 Mayer S A, Yim G K, Onesti S T, Lynch T, Faust P L, Marder K. Biopsy-proven isolated sarcoid meningitis: case report.  J Neurosurg . 1993;  78 994-996
  • 12 Lee S C, Spencer J, Rumberg J, Dickson D W. Isolated central nervous system granulomatosis resembling sarcoidosis.  J Neurol . 1989;  236 356-358
  • 13 James D G. Differential diagnosis of facial nerve palsey.  Sarcoidosis Vasc Diff Lung Dis . 1997;  14 115-120
  • 14 Nowak D A, Widenka D C. Neurosarcoidosis: a review of its intracranial manifestations.  J Neurol . 2001;  248 363-372
  • 15 Martin B, Riskind P N. Neurologic manifestations of hypothalamic disease.  Prog Brain Res . 1992;  931 31-40
  • 16 Bullmann C, Faust M, Hoffmann A. Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis.  Eur J Endocrinol . 2000;  142 365-372
  • 17 Levivier M, Brotchi J, Baleriaux D, Pirotte B, Flament-Durand J. Sarcoidosis presenting as an isolated intramedullary tumor.  Neurosurgery . 1991;  29 271-276
  • 18 Veres L, Utz J B, Houser D W. Sarcoidosis presenting as a central nervous system mass lesion.  Chest . 1997;  111 518-521
  • 19 Mackowiak-Cordoliani M A, De Seze J, Stojkovic T, Ferriby Q, Ingrand D, Vermersch P. Sarcoidosis and progressive multifocal leukoencephalopathy.  Rev Neurol . 2001;  157 547-550
  • 20 Campbell J N, Black P, Ostrow P T. Sarcoid of the cauda equina: case report.  J Neurosurg . 1977;  47 109-112
  • 21 Junger S S, Stern B J, Levine S R, Sipos E, Marti-Masso J F. Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics.  Neurology . 1993;  43 333-337
  • 22 Vinas F C, Rengachary S, Kupsky W J. Spinal cord sarcoidosis: a diagnostic dilemma.  Neurol Res . 2001;  23 347-352
  • 23 Longcope W T, Freiman D. Study of sarcoidosis, based on combined investigations of 160 cases, including 30 autopsies.  Medicine . 1952;  31 1-132
  • 24 Galassi G, Gibertoni G G, Mancini A. Sarcoidosis of the peripheral nerve: clinical, electrophysiological and histological study of two cases.  Eur Neurol . 1984;  23 459-465
  • 25 Gainsborough N, Hall S M, Hughes R A, Leibowitz S. Sarcoid neuropathy.  J Neurol . 1991;  238 177-180
  • 26 Zuniga G, Ropper A H, Frank J. Sarcoid peripheral neuropathy.  Neurology . 1991;  41 1558-1561
  • 27 Scott T S, Brillman J, Gross J A. Sarcoidosis of the peripheral nervous system.  Neurol Res . 1993;  15 389-390
  • 28 Wolfe S M, Pinals R S, Aelion J A, Goodman R E. Myopathy in sarcoidosis: clinical and pathologic study of four cases and review of the literature.  Semen Arthritis Rheum . 1987;  16 300-306
  • 29 Mozaffar T, Lopate G, Pestronk A. Clinical correlates of granulomas in muscle.  J Neurol . 1998;  245 519-524
  • 30 Prayson R A. Granulomatous myositis: clincopathologic study of 12 cases.  Am J Clin Pathol . 1999;  112 63-68
  • 31 Silverstein A, Siltzbach L E. Muscle involvement in sarcoidosis.  Arch Neurol . 1969;  21 235-241
  • 32 Jamal M N, Cilursu A M, Hoffman E L. Sarcoidosis presenting as acute myositis: report and review of the literature.  J Rheumatol . 1988;  15 1868-1871
  • 33 Ost D, Yeldandi A, Cugell D. Acute sarcoid myositis with respiratory muscle involvement.  Chest . 1995;  107 879-882
  • 34 Sohn H S, Kim E N, Park J M, Chung Y A. Muscular sarcoidosis: Ga 67 scintigraphy and magnetic resonance imaging.  Clin Nucl Med . 2001;  26 29-32
  • 35 Otake S. Sarcoidosis involving the skeletal muscle: imaging findings and relative value of imaging procedures.  Am J Roentgenol . 1994;  162 369-375
  • 36 Oksanan V. New cerebrospinal fluid, neurophysiological and neuroradiological examinations in the diagnosis and follow-up of neurosarcoidosis.  Sarcoidosis . 1987;  4 105-110
  • 37 Stern B J, Griffin D E, Luke R A, Krumholz, Johns C T. Neurosarcoidosis: cerebrospinal fluid lymphocyte subpopulations.  Neurology . 1987;  37 878-881
  • 38 Lexa F J, Grossman R I. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy.  Am J Neuroradiol . 1994;  15 973-982
  • 39 Christoforidis G A, Spickler E M, Recio M V, Mehta B M. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment.  Am J Neuroradiol . 1999;  20 655-669
  • 40 Pickuth D, Spielmann R P, Heywang-Kobrunner S H. Role of radiology in the diagnosis of neurosarcoidosis.  Eur Radiol . 2000;  10 941-944
  • 41 Lower E E, Broderick J P, Brott T G, Baughman R P. Diagnosis and management of neurosarcoidosis.  Arch Int Med . 1997;  157 1864-1868
  • 42 Muller-Quernheim J, Kienast K, Held M, Pfeifer S, Costabel U. Treatment of chronic sarcoidosis with an azathioprine/prednisone regimen.  Eur Respir J . 1999;  93 498-506
  • 43 Lewis S J, Ainslie G M, Bateman E D. Efficacy of azathioprine as second-line treatment in pulmonary sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis . 1999;  16 87-92
  • 44 Jones E, Callen J P. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidosis.  J Am Acad Dermatol . 1990;  23 487-489
  • 45 Wallace D J. The use of chloroquine and hydroxychloroquine for noninfectious conditions other than arthritis or lupus: a critical review.  Lupus . 1996;  1 (suppl 5) S59-S64
  • 46 Stern B J, Schonfeld S A, Sewell C, Krumholz A, Scott P, Belendiuk G. Treatment of neurosarcoidosis with cyclosporine.  Arch Neurol . 1992;  49 1065-1072
  • 47 Carlesimo M, Giustini S, Rossi A, Bonaccorsi P, Calvieri S. Treatment of cutaneous and pulmonary sarcoidosis with thalidomide.  J Am Acad Dermatol . 1995;  32 866-869
  • 48 Lee J B, Koblenzer P S. Disfiguring cutaneous manifestations of sarcoidosis treated with thalidomide: a case report.  J Am Acad Dermatol . 1998;  39 835-838
  • 49 Oliver S J, Kikuchi T, Krueger J G, Kaplan G. Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement.  Clin Immunol . 2002;  102 225-236
  • 50 Kataria Y P. Chlorambucil in sarcoidosis.  Chest . 1980;  78 36-43
  • 51 Israel H L, McComb B L. Chlorambicil treatment of sarcoidosis.  Sarcoidosis . 1991;  8 35-41
  • 52 Baughman R P, Lower E E. Infliximab for refractory sarcoidosis.  Sarcoidosis Vasc Diff Lung Dis . 2001;  18 70-74
  • 53 Yee A M, Pochapin M D. Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy.  Ann Int Med . 2001;  135 27-31
  • 54 Sharma O P. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement.  Arch Neurol . 1998;  55 1248-1254
  • 55 Agbogu B N, Stern B J, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis.  Arch Neurol . 1995;  52 875-879
  • 56 Bejar J M, Kerby G R, Ziegler D K, Festoff B W. Treatment of central nervous system sarcoidosis with radiotherapy.  Ann Neurol . 1985;  18 258-260
  • 57 Kang S, Suh J H. Radiation therapy for neurosarcoidosis: report of three cases from a single institution.  Radiat Oncol Investig . 1999;  7 309-312
  • 58 Luke R A, Stern B J, Krumholz A, Johns C J. Neurosarcoidosis: the long-term clinical course.  Neurology . 1987;  37 461-463
  • 59 Perry A, Vuitch F. Causes of death in patients with sarcoidosis: a morphologic study of 38 autopsies with clinicopathologic correlations.  Arch Pathol Lab Med . 1995;  119 167-172
  • 60 Baughman R P. Methotrexate for sarcoidosis.  Sarcoidosis Vasc Diff Lung Dis . 1998;  15 147-149